Table 1.
Main Characteristics of the Study Population.
| Characteristic | Total (n=201) |
ALCL (n=45) |
HL (n=43) |
BL (n=88) |
DLBCL (n=8) |
LBL (n=17) |
|---|---|---|---|---|---|---|
| Gender | ||||||
| Female | 64 | 13 | 25 | 18 | 3 | 5 |
| Male | 137 | 32 | 18 | 70 | 5 | 12 |
| Age (years) | ||||||
| ≤ 10.0 | 98 | 20 | 8 | 56 | 4 | 10 |
| > 10.0 | 103 | 25 | 35 | 32 | 4 | 7 |
| Stage | ||||||
| I+II | 59 | 6 | 18 | 30 | 3 | 2 |
| III+IV | 142 | 39 | 25 | 58 | 5 | 15 |
| LDH UI/L | ||||||
| ≤ 1000 | 97 | 32 | - | 57 | 8 | - |
| >1000 | 37 | 6 | - | 31 | 0 | - |
| B Symptoms | ||||||
| No | 133 | 8* | 23 | 80 | 6 | 16 |
| Yes | 64 | 33 | 20 | 8 | 2 | 1 |
| Bulky disease | ||||||
| No | 113 | 26* | 18* | 53 | 6 | 10 |
| Yes | 84 | 17 | 24 | 35 | 2 | 7 |
| Event (relapse, disease progression) | ||||||
| No | 168 | 31 | 38 | 77 | 8 | 14 |
| Yes | 33 | 14 | 5 | 10 | 0 | 3 |
ALCL, Anaplastic Large Cell Lymphoma; HL, Hodgkin Lymphoma; BL, Burkitt Lymphoma; DLBCL, Diffuse Large B Cell Lymphoma; LBL, Lymphoblastic Lymphoma; LDH, lactate dehydrogenase; *incomplete data available.